Loading...
Apollo Medical Holdings, Inc.
AMEH•NASDAQ
Healthcare
Medical - Care Facilities
$40.82
$-0.88(-2.11%)
Apollo Medical Holdings, Inc. (AMEH) Financial Performance & Statements
Review Apollo Medical Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
46.72%
↑ 46.72%
Operating Income Growth
5.60%
↑ 5.60%
Net Income Growth
-28.93%
↓ 28.93%
Operating Cash Flow Growth
0.00%
Operating Margin
3.09%
↑ 3.09%
Gross Margin
-6.80%
↓ 6.80%
Net Profit Margin
1.42%
↑ 1.42%
ROE
7.03%
↑ 7.03%
ROIC
15.77%
↑ 15.77%
Apollo Medical Holdings, Inc. (AMEH) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Apollo Medical Holdings, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $665.21M | $478.71M | $486.26M | $404.36M |
| Cost of Revenue | $0.00 | $405.22M | $420.25M | $335.50M |
| Gross Profit | $665.21M | $73.49M | $66.02M | $68.86M |
| Gross Profit Ratio | $1.00 | $0.15 | $0.14 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.63M | $37.80M | $35.95M | $38.72M |
| Operating Expenses | $41.63M | $45.07M | $35.95M | $38.72M |
| Total Costs & Expenses | $664.49M | $450.29M | $456.20M | $374.22M |
| Interest Income | $3.22M | $3.78M | $3.51M | $4.00M |
| Interest Expense | -$8.07M | $8.86M | $8.59M | $7.58M |
| Depreciation & Amortization | $8.13M | $7.26M | $7.44M | $5.10M |
| EBITDA | -$1.01M | $42.93M | $47.92M | $36.69M |
| EBITDA Ratio | -$0.002 | $0.09 | $0.08 | $0.09 |
| Operating Income | $720000.00 | $28.43M | $30.07M | $30.14M |
| Operating Income Ratio | $0.001 | $0.06 | $0.06 | $0.07 |
| Other Income/Expenses (Net) | -$2.62M | -$1.61M | $1.83M | -$6.13M |
| Income Before Tax | -$1.90M | $26.81M | $31.90M | $24.004M |
| Income Before Tax Ratio | -$0.003 | $0.06 | $0.07 | $0.06 |
| Income Tax Expense | $5.88M | $7.83M | $10.03M | $7.14M |
| Net Income | -$6.95M | $16.09M | $19.17M | $14.84M |
| Net Income Ratio | -$0.01 | $0.03 | $0.04 | $0.04 |
| EPS | -$0.15 | $0.34 | $0.40 | $0.31 |
| Diluted EPS | -$0.14 | $0.33 | $0.40 | $0.31 |
| Weighted Avg Shares Outstanding | $47.69M | $47.69M | $47.62M | $47.85M |
| Weighted Avg Shares Outstanding (Diluted) | $48.22M | $48.22M | $47.98M | $47.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan